The Australian company incorporated the subsidiary as it plans for the US launch of its ResistancePlus MG assay.
The Singapore-based firm has established a US subsidiary and named distributors to sell its products across Europe, the Middle East, and Asia.
Sweden-based Immunovia is preparing to launch its first diagnostic — a liquid biopsy test for pancreatic cancer — in 2018.
The subsidiary, called ExcitePCR, will own and complete development of the company's Firefly Dx real-time PCR breadboard prototype pathogen detection system.
The subsidiary is being formed in support of Biocartis' recent US distribution deal with Thermo Fisher Scientific.
Ardigen will form a new business unit to conduct biological and clinical data analysis in genomics, transcriptomics, proteomics, metabolomics, and immunomics.
The firm says a direct presence in China will help it expand its reach into a market where it has already sold 60 MassArray systems.
The Geneva-based subsidiary was opened to respond to increasing European demand for the firm's LinkSeq tissue typing test.
The South Korean molecular diagnostics firm plans to grow its global market presence and pursue FDA approval for its products from Seegene Technologies, its new base in California.
NEW YORK (GenomeWeb News) – Analytik Jena today announced that its French subsidiary has begun operations.
US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.
Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.
In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.
In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.